MedImmune, Tech Council of Maryland chart path for region's biotech community

Could Greater Washington be one of the big three in biotech beside other market leaders like, say, Boston?

That was certainly the rallying cry Monday as CEOs and a few hundred entrepreneurs, academics and government types packed into MedImmune’s auditorium in Gaithersburg. MedImmune, the research and development arm of AstraZeneca, was hosting the first Maryland Regional Biotech Forum to chart a course for elevating the region’s reputation into the top three by 2023. The event was also hosted by…